Michel Kaczorek

1.6k total citations
32 papers, 1.3k citations indexed

About

Michel Kaczorek is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Michel Kaczorek has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Immunology and 7 papers in Genetics. Recurrent topics in Michel Kaczorek's work include Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (7 papers) and HIV Research and Treatment (5 papers). Michel Kaczorek is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (7 papers) and HIV Research and Treatment (5 papers). Michel Kaczorek collaborates with scholars based in France, United States and Belgium. Michel Kaczorek's co-authors include Jamal Temsamani, Philippe Clair, Jean‐Michel Scherrmann, Christophe Rousselle, Jeanne-Marie Lefauconnier, Armelle Phalipon, Rolf E. Streeck, Philippe Sansonetti, B. Baudry and Alain Bernard and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Michel Kaczorek

32 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Kaczorek France	18	713	346	169	164	155	32	1.3k
Lana Schaffer United States	23	1.1k 1.5×	429 1.2×	113 0.7×	175 1.1×	154 1.0×	43	1.7k
Torunn Elisabeth Tjelle Norway	23	955 1.3×	599 1.7×	73 0.4×	272 1.7×	166 1.1×	28	2.0k
Daniel Gillet France	27	971 1.4×	691 2.0×	164 1.0×	222 1.4×	284 1.8×	77	2.2k
Peter T. Mora United States	24	955 1.3×	188 0.5×	165 1.0×	329 2.0×	347 2.2×	61	1.6k
Yuji Hidaka Japan	26	1.1k 1.6×	223 0.6×	79 0.5×	300 1.8×	143 0.9×	79	1.8k
E Fries Sweden	17	989 1.4×	277 0.8×	104 0.6×	261 1.6×	58 0.4×	24	1.9k
Patrick Machy France	20	856 1.2×	639 1.8×	371 2.2×	101 0.6×	95 0.6×	40	1.5k
Maria Gallo United States	27	1.1k 1.5×	423 1.2×	367 2.2×	182 1.1×	212 1.4×	65	2.2k
Benjamin Aroeti Israel	25	996 1.4×	165 0.5×	129 0.8×	189 1.2×	72 0.5×	50	1.8k
Tsafi Danieli Israel	17	1.1k 1.6×	141 0.4×	153 0.9×	187 1.1×	130 0.8×	31	1.7k

Countries citing papers authored by Michel Kaczorek

Since Specialization

Citations

This map shows the geographic impact of Michel Kaczorek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Kaczorek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Kaczorek more than expected).

Fields of papers citing papers by Michel Kaczorek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Kaczorek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Kaczorek. The network helps show where Michel Kaczorek may publish in the future.

Co-authorship network of co-authors of Michel Kaczorek

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Kaczorek. A scholar is included among the top collaborators of Michel Kaczorek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Kaczorek. Michel Kaczorek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Temsamani, Jamal, Cécile Bonnafous, Christophe Rousselle, et al.. (2005). Improved Brain Uptake and Pharmacological Activity Profile of Morphine-6-Glucuronide Using a Peptide Vector-Mediated Strategy. Journal of Pharmacology and Experimental Therapeutics. 313(2). 712–719. 26 indexed citations

2.

Zhang, Yu, Philippe Clair, Kenneth H. Grabstein, et al.. (2003). Induction of Antigen-Specific CTL Responses Using Antigens Conjugated to Short Peptide Vectors. The Journal of Immunology. 170(3). 1498–1503. 8 indexed citations

3.

Casset, Florence, Florence Roux‐Dalvai, Patrick Mouchet, et al.. (2003). A peptide mimetic of an anti-CD4 monoclonal antibody by rational design. Biochemical and Biophysical Research Communications. 307(1). 198–205. 31 indexed citations

4.

Drin, Guillaume, Martine Mazel, Philippe Clair, et al.. (2001). Physico‐chemical requirements for cellular uptake of pAntp peptide. European Journal of Biochemistry. 268(5). 1304–1314. 120 indexed citations

5.

Rousselle, Christophe, Philippe Clair, Jeanne-Marie Lefauconnier, et al.. (2000). New Advances in the Transport of Doxorubicin through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy. Molecular Pharmacology. 57(4). 679–686. 284 indexed citations

6.

Rousselle, Christophe, Philippe Clair, Jeanne-Marie Lefauconnier, et al.. (2000). New Advances in the Transport of Doxorubicin through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy. Molecular Pharmacology. 57(4). 679–686. 8 indexed citations

7.

Fabbrizio, Eric, Laurent Le Cam, Jolanta Polanowska, et al.. (1999). Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene. 18(30). 4357–4363. 69 indexed citations

8.

Grassy, Gérard, Bernard Calas, Abdelaziz Yasri, et al.. (1998). Computer-assisted rational design of immunosuppressive compounds. Nature Biotechnology. 16(8). 748–752. 75 indexed citations

9.

Edelman, L., Hassan Chaabihi, Dominique Blanchard, et al.. (1997). Obtaining a functional recombinant anti‐rhesus (D) antibody using the baculovirus–insect cell expression system. Immunology. 91(1). 13–19. 22 indexed citations

10.

Poul, Marie‐Alix, et al.. (1995). Design of cassette baculovirus vectors for the production of therapeutic antibodies in insect cells. Immunotechnology. 1(3-4). 189–196. 21 indexed citations

11.

Poul, Marie‐Alix, Martine Cérutti, Hassan Chaabihi, et al.. (1995). Cassette baculovirus vectors for the production of chimeric, humanized, or human antibodies in insect cells. European Journal of Immunology. 25(7). 2005–2009. 29 indexed citations

12.

Michel, Frédérique, Agnès Hoffenbach, Patrick Froussard, et al.. (1992). HIV-1 Env, Nef , and Gag -Specific T-Cell Immunity in Mice: Conserved Epitopes in Nef P27 and Gag P25 Proteins. AIDS Research and Human Retroviruses. 8(4). 469–478. 11 indexed citations

13.

Dedieu, Jean-François, et al.. (1992). High-Titer HIV-1 Neutralizing Antibody Response of Rhesus Macaques to gp160 and env Peptides. AIDS Research and Human Retroviruses. 8(6). 1117–1123. 9 indexed citations

14.

Charbit, Alain, J F Dedieu, M Mancini, et al.. (1991). Is There a Neutralization Epitope in the Second Conserved Domain of HIV-1 Envelope Protein?. AIDS Research and Human Retroviruses. 7(1). 1–2. 9 indexed citations

15.

Thomas, Daniel, J.S. Wall, James F. Hainfeld, et al.. (1991). gp160, the envelope glycoprotein of human immunodeficiency virus type 1, is a dimer of 125-kilodalton subunits stabilized through interactions between their gp41 domains. Journal of Virology. 65(7). 3797–3803. 55 indexed citations

16.

Céfaï, Daniel, Patrice Debré, Michel Kaczorek, et al.. (1990). Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway.. Journal of Clinical Investigation. 86(6). 2117–2124. 56 indexed citations

17.

Phalipon, Armelle, R Crainic, & Michel Kaczorek. (1989). Expression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein. Vaccine. 7(2). 132–136. 5 indexed citations

18.

Cabiaux, Véronique, Armelle Phalipon, Ruddy Wattiez, et al.. (1988). Expression of a biologically active diphtheria toxin fragment B in Escherichia coli. Molecular Microbiology. 2(3). 339–346. 8 indexed citations

19.

Phalipon, Armelle & Michel Kaczorek. (1987). Genetically engineered diphtheria toxin fusion proteins carrying the hepatitis B surface antigen. Gene. 55(2-3). 255–263. 9 indexed citations

20.

Marx, Maria, et al.. (1981). Continuous production of rous sarcoma virus free of transformation defective virus in clones of established RSV-transformed quail cells. Virology. 115(1). 10–19. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact